Australia markets open in 3 hours 13 minutes

23andMe Holding Co. (ME)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9200-0.0100 (-0.34%)
At close: 04:00PM EDT
2.9400 +0.02 (+0.68%)
After hours: 04:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.9300
Open2.8800
Bid2.9000 x 3200
Ask2.9500 x 2900
Day's range2.8800 - 3.0600
52-week range2.1500 - 13.6800
Volume2,152,197
Avg. volume3,480,957
Market cap1.306B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Investors one-year losses grow to 69% as the stock sheds US$72m this past week

    Investing in stocks comes with the risk that the share price will fall. And unfortunately for 23andMe Holding Co...

  • Motley Fool

    23andMe CEO Anne Wojcicki on Bringing Health Information Directly to People

    In this podcast, Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe (NASDAQ: ME), about her company and why it's looking to tell you much more than the names of your long-lost relatives. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. Anne Wojcicki: [MUSIC] When I think one of our legacies, hopefully, will be, is that 23andme has really proven that complicated information can go direct to a consumer, it does not have to have a one-to-one interaction with the physician.

  • Motley Fool

    This Exciting Biotech Stock Could Be Your Next 10-Bagger

    The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live, recorded on March 28, Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising business plans that could pay off in a big way over the next few years.